News Headlines Article

FDA outlines steps to enhance agency’s post-market drug safety program
Modern Healthcare

The Food and Drug Administration said the agency now provides as much effort in monitoring the safety of approved drugs as it does during the pre-market drug review process. The FDA released three reports on Saturday that outline the steps its Center for Drug Evaluation and Research has taken to enhance the agency’s postmarket drug safety program.

Commands